Pure Global

Percutaneous radio-frequency ablation probe, tumour-ablation, bipolar - UK MHRA Medical Device Registration

Percutaneous radio-frequency ablation probe, tumour-ablation, bipolar is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 101594. The device is manufactured by STARmed CO LTD from South Korea, classified as General Medical Device. The authorized representative in the UK is Emergo Consulting (UK) Limited .

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
General Medical Device
๐Ÿ‡ฌ๐Ÿ‡ง
Percutaneous radio-frequency ablation probe, tumour-ablation, bipolar
MHRA Device ID: 101594โ€ขRef: 101594

Device Type

General Medical Device

Devices

Percutaneous radio-frequency ablation probe, tumour-ablation, bipolar

Type

Class IIb

Date Registered

Jul 8, 2024

Last Updated

Apr 17, 2024

Manufacturer Information

Address

158 Haneulmaeul-ro Ilsandong-gu

Gyeonggi-do, Goyang-si, South Korea

Created Date

Aug 31, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

Compass House, Vision Park Histon c/o Cr360 โ€“ UL International

Cambridge, England, United Kingdom

Postcode: CB24 9BZ

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing